Page last updated: 2024-08-05 12:54:11
pyranopyridine
null
ChEBI ID: 38192
Members (15)
Member | Definition | Role |
2-amino-4-(2-ethoxyphenyl)-6,7-dimethyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carbonitrile | | 2-amino-4-(2-ethoxyphenyl)-6,7-dimethyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carbonitrile |
2-amino-4-(2-ethoxyphenyl)-7-methyl-5-oxo-6-(2-pyridinylmethyl)-4H-pyrano[3,2-c]pyridine-3-carbonitrile | | 2-amino-4-(2-ethoxyphenyl)-7-methyl-5-oxo-6-(2-pyridinylmethyl)-4H-pyrano[3,2-c]pyridine-3-carbonitrile |
2-amino-4-(3-chlorophenyl)-6-(2-furanylmethyl)-7-methyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carboxylic acid methyl ester | | 2-amino-4-(3-chlorophenyl)-6-(2-furanylmethyl)-7-methyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carboxylic acid methyl ester |
2-amino-6-(2-furanylmethyl)-7-methyl-5-oxo-4-(3-pyridinyl)-4H-pyrano[3,2-c]pyridine-3-carbonitrile | | 2-amino-6-(2-furanylmethyl)-7-methyl-5-oxo-4-(3-pyridinyl)-4H-pyrano[3,2-c]pyridine-3-carbonitrile |
2-amino-6-[3-(1-imidazolyl)propyl]-4-(2-methoxyphenyl)-7-methyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carbonitrile | | 2-amino-6-[3-(1-imidazolyl)propyl]-4-(2-methoxyphenyl)-7-methyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carbonitrile |
2-amino-7-methyl-6-[3-(4-morpholinyl)propyl]-5-oxo-4-(2,4,5-trimethoxyphenyl)-4H-pyrano[3,2-c]pyridine-3-carbonitrile | | 2-amino-7-methyl-6-[3-(4-morpholinyl)propyl]-5-oxo-4-(2,4,5-trimethoxyphenyl)-4H-pyrano[3,2-c]pyridine-3-carbonitrile |
6-[2-(dimethylamino)ethylamino]-8-(2-furanyl)-3,3-dimethyl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile | | 6-[2-(dimethylamino)ethylamino]-8-(2-furanyl)-3,3-dimethyl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile |
7,7-dimethyl-2-(1-pyrrolidinyl)-5,8-dihydropyrano[4,3-b]pyridine-3-carbonitrile | | 7,7-dimethyl-2-(1-pyrrolidinyl)-5,8-dihydropyrano[4,3-b]pyridine-3-carbonitrile |
gentianine | | gentianine |
LSM-16947 | | LSM-16947 |
LSM-17147 | | LSM-17147 |
LSM-20899 | | LSM-20899 |
LSM-24516 | | LSM-24516 |
LSM-28187 | | LSM-28187 |
LSM-28572 | | LSM-28572 |
Research
Studies (21)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
pre-1990 | 1 (4.76) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (14.29) | 29.6817 |
2010's | 12 (57.14) | 24.3611 |
2020's | 5 (23.81) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (1.16%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 85 (98.84%) | 84.16% |